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Purpose：Normal corneal epithelial barrier plays a important role in maintaining 
corneal homeostasis and protect cornea from invastion. At present we already know 
that ocular trauma, inflammation, metabolic disorders could change the distribution 
and expression of corneal superficial epithelium junction, and could lead to 
dysfunction of corneal epithelial barrier function. Corneal epithelial barrier 
dysfunction is the pathological basis of various ocular surface diseases. It has been 
confirmed that corneal nerves could communicate and contact with corneal epithelium. 
Our study intended to explore the effect of bilateral corneal epithelial barrier function 
after severing unilateral corneal nerves, and the possible mechanism of this 
phenomenon. 
Method：The normal wistar rats were randomly divided into three groups by 
different methods: control group, trephine treated group, scratched "×" group, each 
group had 30 rats in it. Trephine treated group means we used 3.00 mm diameter core 
trephine cut from corneal epithelium to stromal, which was about two-thirds of 
corneal stromal layer deep, the contralateral eye didn't do any test. We scratched two 
perpendicular lines about 3.00 mm diameter with a blade paddle on the cornea. The 
contralateral eye didn’t do any test. Then we assessed the ocular surface of 
experimental rats on day 1, day 7, day 14, did the following clinical index detection: 1. 
corneal sensation, 2. sodium fluorescein staining, 3. tear secretion measurement. We 
did hematoxylin-eosin (HE) staining to observe the morphological changes in corneal 
epithelium, and whole mount corneas were analyzed by fluorescence confocal 
microscopy to observe the presense of tight junction marker ZO-1 and adhesive 
junction marker E-cadherin, substance P and cell proliferation markers Ki67 in cornea 
epithelium. TUNEL kit was used to detect corneal epithelial cells apoptosis. Western 
blot and Real-time PCR technique were used to detect ZO-1 protein and mRNA 















neurokinin-1 receptor（NK-1R）, interleukins-1β（IL-1β）, tumor necrosis factor-α
（TNF-α）, vascular endothelial growth factor-a (VEGF-a ) by Real-time PCR . 
Results: After severing unilateral corneal nerves of rats, bilateral corneal 
sensation and tear secretion are both decreased, corneal sodium fluorescein staining 
scores were bilateral rised. The corneal epithelium morphology didn’t change 
significantly in each group. Fluorescein staining showed that after severing the 
corneal nerves, the corneal nerves density was reduced. The center corneal area cutted 
by trephine had no nerves after 2 weeks. The contralateral eye of trephine group 
corneal nerves density was reduced too. The distribution of ZO-1 and E-cadherin were 
dispersed in the bilateral cornea of trephine group. The protein and mRNA expression 
of ZO-1 in the trephine treated group were reduced in bilateral corneal epithelium. In 
the bilateral cornea of trephine group, proliferation and apoptosis cells were active 
compared with control group. In the bilateral cornea of trephine group substance P 
and NK-1R mRNA expression level were increased, and inflammatory factor IL-1β, 
TNF-α, VEGF-a mRNA expression level were increased as well. Scratch "×" group 
the distribution of ZO-1 and E-cadherin as well as the mRNA expression of substance 
P, NK-1R, IL-1β, VEGF-a were changed only on the first day, but showed no 
significant changes after 7 and 14 days. The scrach "×" group contralateral eye had no 
significant changes compared with the control group. 
Conclusion: After severing the unilateral corneal nerves, bilateral corneal 
epithelial barrier function disfunction occurred. Meanwhile we found that bilateral 
corneal substance P, NK-1R expression and inflammatory cytokines were also 
increased after severing the corneal nerves. Corneal epithelial barrier disfunction was 
caused by corneal nerves damage; it’s probably due to the upregulation of substance P 
and inflammatory cytokines. 
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第一章  前言  
1.1 角膜的组织结构和生理功能  


















































5-11 或 7-1点方位。B.上皮下神经丛的适应性分布方向[2]。 
资料来源：Muller LJ, Marfurt CF, Kruse F，Corneal nerves: structure, contents and 
function，Exp Eye Res，2013年5月。 
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